Fumarates and Cancer.

Abstract:

:Accumulation of intermediate metabolites of the tricarboxylic acid (TCA) cycle in tumor cells can cause epithelial-to-mesenchymal transition (EMT), although the exact mechanisms remain elusive. Recent studies show that the oncometabolite fumarate, which accumulates in fumarate hydratase-deficient renal cancers, confers tumor aggressiveness by causing epigenetic changes in the antimetastatic miRNA cluster mir-200ba429. This may have important implications for the use of fumarates in the clinic.

journal_name

Trends Mol Med

authors

Fuhler GM,Eppinga H,Peppelenbosch MP

doi

10.1016/j.molmed.2016.12.001

subject

Has Abstract

pub_date

2017-01-01 00:00:00

pages

3-5

issue

1

eissn

1471-4914

issn

1471-499X

pii

S1471-4914(16)30186-1

journal_volume

23

pub_type

杂志文章
  • Protein S-nitrosylation in health and disease: a current perspective.

    abstract::Protein S-nitrosylation constitutes a large part of the ubiquitous influence of nitric oxide on cellular signal transduction and accumulating evidence indicates important roles for S-nitrosylation both in normal physiology and in a broad spectrum of human diseases. Here we review recent findings that implicate S-nitro...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2009.06.007

    authors: Foster MW,Hess DT,Stamler JS

    更新日期:2009-09-01 00:00:00

  • Direct Effects of Anti-Angiogenic Therapies on Tumor Cells: VEGF Signaling.

    abstract::Over recent decades anti-angiogenic therapies (AATs) have produced promising results in the treatment of different malignancies. Unfortunately, resistance often develops and patients ultimately relapse. In an attempt to elucidate the causes of recurrence, most studies have focused on tumor responses to hypoxic conditi...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2017.01.002

    authors: Simon T,Gagliano T,Giamas G

    更新日期:2017-03-01 00:00:00

  • mTOR: A pathogenic signaling pathway in developmental brain malformations.

    abstract::The mTOR signaling network functions as a pivotal regulatory cascade during the development of the cerebral cortex. Aberrant hyperactivation of mTOR as a consequence of loss-of-function gene mutations encoding mTOR inhibitor proteins such as TSC1, TSC2, PTEN and STRADα has been recently linked to developmental cortica...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2011.07.008

    authors: Crino PB

    更新日期:2011-12-01 00:00:00

  • Foci on fanconi.

    abstract::The protein network protecting the stability of the genome is defective in Fanconi anemia (FA). The newest in a series of FA proteins is involved in DNA damage response, but the mechanism is still unclear. Clues may come from yeast two-hybrid experiments, an extraordinarily successful tool for determining molecular fu...

    journal_title:Trends in molecular medicine

    pub_type: 新闻

    doi:10.1016/s1471-4914(01)02042-1

    authors: Hoatlin M,Reuter T

    更新日期:2001-06-01 00:00:00

  • Considering the Immune System during Fecal Microbiota Transplantation for Clostridioides difficile Infection.

    abstract::Our understanding and utilization of fecal microbiota transplantation (FMT) has jump-started over the past two decades. Recent technological advancements in sequencing and metabolomics have allowed for better characterization of our intestinal microbial counterparts, triggering a surge of excitement in the fields of m...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2020.01.009

    authors: Frisbee AL,Petri WA Jr

    更新日期:2020-05-01 00:00:00

  • Avoiding a Sticky Situation: Bypassing the Mucus Barrier for Improved Local Drug Delivery.

    abstract::The efficacy of drugs administered by traditional routes is limited by numerous biological barriers that preclude reaching the intended site of action. Further, full body systemic exposure leads to dose-limiting, off-target side effects. Topical formulations may provide more efficacious drug and nucleic acid delivery ...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2020.12.001

    authors: Zierden HC,Josyula A,Shapiro RL,Hsueh HT,Hanes J,Ensign LM

    更新日期:2021-01-04 00:00:00

  • Biomarker Potential of Extracellular miRNAs in Duchenne Muscular Dystrophy.

    abstract::miRNAs are small, noncoding RNAs that not only regulate gene expression within cells, but might also constitute promising extracellular biomarkers for a variety of pathologies, including the progressive muscle-wasting disorder Duchenne Muscular Dystrophy (DMD). A set of muscle-enriched miRNAs, the myomiRs (miR-1, miR-...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2017.09.002

    authors: Coenen-Stass AML,Wood MJA,Roberts TC

    更新日期:2017-11-01 00:00:00

  • Immunotherapy: target the stroma to hit the tumor.

    abstract::For decades it has been assumed that T cells reject tumors essentially by direct killing. However, solid tumors are composed of malignant cells and a variety of different nonmalignant cells, referred to as tumor stroma. Stromal cells, such as endothelial cells, fibroblasts and inflammatory cells, often support tumor g...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2005.03.002

    authors: Kammertoens T,Schüler T,Blankenstein T

    更新日期:2005-05-01 00:00:00

  • Molecular and immune toxicity of CoCr nanoparticles in MoM hip arthroplasty.

    abstract::Theoretical, desirable features of second-generation metal-on-metal (MoM) hip prostheses have led to their widespread use. However, the bearing surfaces, consisting of complex cobalt-chromium alloys, are subject to wear and the release of cobalt and chromium (CoCr) nanoparticles. These nanoparticles can reduce cellula...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2011.12.002

    authors: Gill HS,Grammatopoulos G,Adshead S,Tsialogiannis E,Tsiridis E

    更新日期:2012-03-01 00:00:00

  • Modeling Pancreatic Cancer through Somatic Editing with AAV.

    abstract::Genetically engineered mouse models have revolutionized the study of pancreatic cancer, but have several technical and practical limitations. A new adeno-associated virus (AAV)-driven somatic genome-editing model of pancreatic ductal adenocarcinoma reported by Ideno et al. (Lab. Invest. published online February 6, 20...

    journal_title:Trends in molecular medicine

    pub_type: 信件

    doi:10.1016/j.molmed.2019.02.012

    authors: Curiel-GarcÍa A,Olive KP

    更新日期:2019-05-01 00:00:00

  • Genomics and personalised whole-of-life healthcare.

    abstract::Genome sequencing has the potential for stratified cancer treatment and improved diagnostics for rare disorders. However, sequencing needs to be utilised in risk stratification on a population scale to deepen the impact on the health system by addressing common diseases, where individual genomic variants have variable...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2014.04.001

    authors: Bauer DC,Gaff C,Dinger ME,Caramins M,Buske FA,Fenech M,Hansen D,Cobiac L

    更新日期:2014-09-01 00:00:00

  • Osteoclast-derived activity in the coupling of bone formation to resorption.

    abstract::The cells of bone and the immune system communicate by means of soluble and membrane-bound cytokines and growth factors. Through local signalling mechanisms, cells of the osteoblast lineage control the formation and activity of osteoclasts and, therefore, the resorption of bone. Both T and B lymphocytes produce activa...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2004.12.004

    authors: Martin TJ,Sims NA

    更新日期:2005-02-01 00:00:00

  • Lessons from models of SOD1-linked familial ALS.

    abstract::Ten years ago, the linkage between mutations in the gene coding for the antioxidant enzyme Cu,Zn superoxide dismutase (SOD1) and the neurodegenerative disease known as familial amyotrophic lateral sclerosis (FALS) was established. This finding has prompted a myriad of new studies in experimental models aimed at invest...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2004.06.009

    authors: Bendotti C,Carrì MT

    更新日期:2004-08-01 00:00:00

  • Kaposi's sarcoma as a model for cancer immunotherapy.

    abstract::Physicians have, for over a century, attempted to harness the potential therapeutic power of the immune system to treat patients with cancer. The discovery that cancer regression can be achieved by immune rejection of tumour antigens theoretically allows the eradication of neoplastic cells without toxicity to normal t...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2004.02.006

    authors: Stebbing J,Bower M,Srivastava P

    更新日期:2004-04-01 00:00:00

  • MLL: a histone methyltransferase disrupted in leukemia.

    abstract::Rearrangements of the MLL gene, which is located at chromosome 11q23, are associated with aggressive acute leukemias in both children and adults. MLL regulates Hox gene expression through direct promoter binding and histone modification. MLL rearrangements occurring in leukemia include MLL fusion genes, partial tandem...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2004.08.005

    authors: Hess JL

    更新日期:2004-10-01 00:00:00

  • ANGPTL4 in Metabolic and Cardiovascular Disease.

    abstract::Alterations in circulating lipids and ectopic lipid deposition impact on the risk of developing cardiovascular and metabolic diseases. Lipoprotein lipase (LPL) hydrolyzes fatty acids (FAs) from triglyceride (TAG)-rich lipoproteins including very low density lipoproteins (VLDLs) and chylomicrons, and regulates their di...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2019.05.010

    authors: Aryal B,Price NL,Suarez Y,Fernández-Hernando C

    更新日期:2019-08-01 00:00:00

  • Boosting Antitumour Immunity through Targeted Delivery of Interferon-α.

    abstract::Immune checkpoint inhibitors (ICIs) have revolutionised cancer immunotherapy but their success is wholly dependent on amplifying an existing immune response directed against the tumour. A recent study by Tsuchiya et al. suggests how the properties of induced pluripotent stem cells (iPSCs) may be exploited for the targ...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2019.09.001

    authors: Fairchild PJ,Davies TJ

    更新日期:2019-11-01 00:00:00

  • Nitric-oxide-donating NSAIDs as agents for cancer prevention.

    abstract::Nitric-oxide-donating nonsteroidal anti-inflammatory drugs (NO-NSAIDs), which consist of an NSAID with an NO-donating moiety covalently attached to it, promise to contribute significantly towards the development of effective chemoprevention strategies against cancer. NO-NSAIDs inhibit the growth of cultured cancer cel...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2004.05.004

    authors: Rigas B,Kashfi K

    更新日期:2004-07-01 00:00:00

  • A tale of two tails: ciliary mechanotransduction in ADPKD.

    abstract::Autosomal dominant polycystic kidney disease (ADPKD) is a common lethal genetic disorder, characterized by the progressive development of fluid-filled cysts in the kidney, pancreas and liver, and anomalies of the cardiovascular system. Mutations in PKD1 and PKD2, which encode the transmembrane proteins polycystin-1 (P...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章

    doi:10.1016/s1471-4914(03)00073-x

    authors: Cantiello HF

    更新日期:2003-06-01 00:00:00

  • Soluble amyloid precursor proteins and secretases as Alzheimer's disease biomarkers.

    abstract::Recently revised diagnostic guidelines for Alzheimer's disease (AD) emphasise the use of biomarkers, heralding a paradigm shift towards a more biological definition of the disorder. Currently available biomarkers offer added diagnostic accuracy in certain situations, but their performance in terms of early diagnostic ...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2013.10.001

    authors: Perneczky R,Alexopoulos P,Kurz A

    更新日期:2014-01-01 00:00:00

  • Learning from Jekyll to control Hyde: Hedgehog signaling in development and cancer.

    abstract::The Hedgehog (Hh) cascade controls cell proliferation, differentiation and patterning of tissues during embryogenesis but is largely suppressed in the adult. The Hh pathway can become reactivated in cancer. Here, we assimilate data from recent studies to understand how and when the Hh pathway is turned on to aid the n...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2010.05.003

    authors: Barakat MT,Humke EW,Scott MP

    更新日期:2010-08-01 00:00:00

  • Dispelling myths and focusing on notable concepts in HIV pathogenesis.

    abstract::Since the discovery of HIV over three decades ago, major efforts have been made to control and perhaps eliminate HIV infection worldwide. During these studies, certain myths or misconceptions about this infectious disease have been emphasized and other potentially beneficial concepts have received less attention. A tr...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2015.03.004

    authors: Levy JA

    更新日期:2015-06-01 00:00:00

  • An Intestinal Inflammasome - The ILC3-Cytokine Tango.

    abstract::The inflammasome is a key regulator of immune responses in the gut. Two recent studies in the journal Cell demonstrate that epithelial inflammasome activation and IL-18 secretion can control intestinal homeostasis or induce autoinflammation. ILC3 cells are triggered to secrete IL-22, regulating IL-18 expression in epi...

    journal_title:Trends in molecular medicine

    pub_type: 评论,杂志文章

    doi:10.1016/j.molmed.2016.02.008

    authors: Gonçalves P,Di Santo JP

    更新日期:2016-04-01 00:00:00

  • Signaling to NF-kappaB by Toll-like receptors.

    abstract::Innate immunity is the first line of defense against invading pathogens. A family of Toll-like receptors (TLRs) acts as primary sensors that detect a wide variety of microbial components and elicit innate immune responses. All TLR signaling pathways culminate in activation of the transcription factor nuclear factor-ka...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2007.09.002

    authors: Kawai T,Akira S

    更新日期:2007-11-01 00:00:00

  • Neuronal Regulation of eIF2α Function in Health and Neurological Disorders.

    abstract::A key site of translation control is the phosphorylation of the eukaryotic translation initiation factor 2α (eIF2α), which reduces the rate of GDP to GTP exchange by eIF2B, leading to altered translation. The extent of eIF2α phosphorylation within neurons can alter synaptic plasticity. Phosphorylation of eIF2α is trig...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2018.04.001

    authors: Moon SL,Sonenberg N,Parker R

    更新日期:2018-06-01 00:00:00

  • Surviving Acute Organ Failure: Cell Polyploidization and Progenitor Proliferation.

    abstract::In acute organ failure, rapid compensation of function loss assures survival. Dedifferentiation and/or proliferation of surviving parenchymal cells could imply a transient (and potentially fatal) impairment of residual functional performance. However, evolution has selected two flexible life-saving mechanisms acting s...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2019.02.006

    authors: Lazzeri E,Angelotti ML,Conte C,Anders HJ,Romagnani P

    更新日期:2019-05-01 00:00:00

  • RANKL-RANK signaling in osteoclastogenesis and bone disease.

    abstract::Hundreds of millions of people worldwide are affected by bone-related diseases, such as osteoporosis and rheumatoid arthritis. Understanding the molecular mechanisms of bone metabolism is crucial for developing novel drugs for treating such diseases. In particular, genetic experiments showing that the receptor activat...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2005.11.007

    authors: Wada T,Nakashima T,Hiroshi N,Penninger JM

    更新日期:2006-01-01 00:00:00

  • MicroRNA Regulators of Anxiety and Metabolic Disorders.

    abstract::Anxiety-related and metabolic disorders are under intense research focus. Anxiety-induced microRNAs (miRNAs) are emerging as regulators that are not only capable of suppressing inflammation but can also induce metabolic syndrome-related processes. We summarize here evidence linking miRNA pathways which share regulator...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2016.07.001

    authors: Meydan C,Shenhar-Tsarfaty S,Soreq H

    更新日期:2016-09-01 00:00:00

  • Dual action of glatiramer acetate (Cop-1) in the treatment of CNS autoimmune and neurodegenerative disorders.

    abstract::Protective autoimmunity is the body's defense mechanism against destructive self-compounds such as those commonly associated with neurodegenerative disorders. Autoimmune disease and neurodegenerative disorders can thus be viewed as two extreme manifestations of the same process. Therefore, when designing therapy, it i...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4914(02)02373-0

    authors: Kipnis J,Schwartz M

    更新日期:2002-07-01 00:00:00

  • Non-viral and hybrid vectors in human gene therapy: an update.

    abstract::Non-viral DNA vectors have several advantages over viral vectors. For example, virus production is expensive and there are safety concerns regarding viral manipulations. In addition, the size of the delivered plasmid is limited by the size of the viral capsid, whereas this is not a problem with non-viral vectors. The ...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4914(03)00005-4

    authors: Schmidt-Wolf GD,Schmidt-Wolf IG

    更新日期:2003-02-01 00:00:00